Evidence map›Paper›PMID 41272166›Full record

ArticleNature immunology2025

Sequential lymphotoxin-β receptor and retinoic acid receptor signals regulate cDC2 fate.

Albert A Nguyen, Logan Fisher, Jennifer S Y Ahn, Michelle Zuo, Tyler Park, Anushka Yadav, Miki S Gams, Kei Haniuda, Dragos C Dasoveanu, Conglei Li and 11 more

Abstract read
In one paragraph

Article in Nature immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Albert A Nguyen *Department of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-8724-7476
Logan Fisher *Immunology and Microbial Pathogenesis Program, Weill Cornell Medicine Graduate School of Medical Sciences, New York, NY, USA.ORCID http://orcid.org/0000-0003-4680-1527
Jennifer S Y AhnDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0009-0005-5305-8956
Michelle ZuoDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-6704-453X
Tyler ParkComputational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-1246-1544
Anushka YadavHoward Hughes Medical Institute and Immuno-Oncology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-4333-6028
Miki S GamsDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Kei HaniudaDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-9313-6542
Dragos C DasoveanuDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Conglei LiDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Lesley A WardDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Angela A WangDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-6991-7368
Zakieh TayyebiComputational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-7821-9905
Daria TrofimovaDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Trevor McKeeDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-2195-6146
Cathy L MendelsohnDepartment of Pathology and Cell Biology, Columbia University, New York, NY, USA.
John S AllinghamComputational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Cynthia J GuidosDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-7674-2612
Blandine MaîtreDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Jennifer L GommermanDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada. jen.gommerman@utoronto.ca.ORCID http://orcid.org/0000-0003-4576-6168
Chrysothemis C BrownImmunology and Microbial Pathogenesis Program, Weill Cornell Medicine Graduate School of Medical Sciences, New York, NY, USA. brownc10@mskcc.org.ORCID http://orcid.org/0000-0002-5834-926X

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Acceptance of non-self: Decoding intestinal immune tolerance during early lifeDP2AI171116 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI Chrysothemis Brown · 2022 to 2026
$2.7M
Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) FDN-159922Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) FRN-165973Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) PJT-195705NCI NIH HHS P30 CA008748NIAID NIH HHS DP2 AI171116U.S. Department of Health & Human Services | National Institutes of Health (NIH) DP2AI171116
6 · The paper itself

Abstract

Type 2 conventional dendritic cells (cDC2s) are functionally and phenotypically heterogenous. Previous work in mice and humans identified two cDC2 subsets (cDC2As and cDC2Bs) and a monocytic DC3 subset. However, the microenvironmental cues governing their distinct differentiation pathways remain unclear. Here, we delineate mouse cDC2 lineage relationships and the sequential signals required for cDC2A maintenance. We show that cDC2s, arising from the CLEC9A

Indexed as

Dendritic CellsLymphotoxin beta ReceptorReceptors, Retinoic AcidAnimalsCell DifferentiationCell LineageHumansMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicSignal TransductionSpleenTretinoinLymphotoxin beta ReceptorReceptors, Retinoic AcidTretinoin

Identifiers

PMID41272166
PMCPMC13265045

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.